{
    "Trade/Device Name(s)": [
        "Diazyme D-Dimer Assay Kit",
        "Diazyme D-Dimer Assay Calibrator Set",
        "Diazyme D-Dimer Assay Control Set"
    ],
    "Submitter Information": "Diazyme Laboratories",
    "510(k) Number": "K112120",
    "Predicate Device Reference 510(k) Number(s)": [
        "K062203"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GHH",
        "DAP",
        "JIT"
    ],
    "Summary Letter Date": "January 17, 2013",
    "Summary Letter Received Date": "January 18, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.7320"
    ],
    "Regulation Name(s)": [
        "Fibrinogen/fibrin degradation products assay"
    ],
    "Analyte Class(es)": [
        "hematology",
        "coagulation"
    ],
    "Analyte(s)": [
        "D-Dimer"
    ],
    "Specimen Type(s)": [
        "Human plasma",
        "Human citrated plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Latex enhanced immunoturbidimetric assay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Diazyme D-Dimer Assay Kit, Calibrator Set, and Control Set for quantitative measurement of D-Dimer in human plasma using latex enhanced immunoturbidimetric assay.",
    "Indications for Use Summary": "Quantitative determination of fibrinogen/fibrin degradation products (D-Dimer) in human plasma as an aid in detecting intravascular coagulation and fibrinolysis; calibrator and control sets for calibration and quality control of the assay.",
    "fda_folder": "Hematology"
}